BRPI0922716A2 - purificação de polipeptídeo - Google Patents

purificação de polipeptídeo

Info

Publication number
BRPI0922716A2
BRPI0922716A2 BRPI0922716A BRPI0922716A BRPI0922716A2 BR PI0922716 A2 BRPI0922716 A2 BR PI0922716A2 BR PI0922716 A BRPI0922716 A BR PI0922716A BR PI0922716 A BRPI0922716 A BR PI0922716A BR PI0922716 A2 BRPI0922716 A2 BR PI0922716A2
Authority
BR
Brazil
Prior art keywords
polypeptide purification
polypeptide
purification
Prior art date
Application number
BRPI0922716A
Other languages
English (en)
Portuguese (pt)
Inventor
Jais Rose Bjelke
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of BRPI0922716A2 publication Critical patent/BRPI0922716A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6437Coagulation factor VIIa (3.4.21.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21021Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
BRPI0922716A 2008-12-02 2009-12-01 purificação de polipeptídeo BRPI0922716A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08170454 2008-12-02
PCT/EP2009/066149 WO2010063717A1 (en) 2008-12-02 2009-12-01 Polypeptide purification

Publications (1)

Publication Number Publication Date
BRPI0922716A2 true BRPI0922716A2 (pt) 2016-11-01

Family

ID=40404199

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922716A BRPI0922716A2 (pt) 2008-12-02 2009-12-01 purificação de polipeptídeo

Country Status (12)

Country Link
US (1) US20110287518A1 (https=)
EP (1) EP2373677B1 (https=)
JP (1) JP5788803B2 (https=)
KR (1) KR101821143B1 (https=)
CN (1) CN102239175A (https=)
AU (1) AU2009324204B2 (https=)
BR (1) BRPI0922716A2 (https=)
CA (1) CA2742246A1 (https=)
ES (1) ES2576109T3 (https=)
MX (1) MX2011005474A (https=)
RU (1) RU2544860C2 (https=)
WO (1) WO2010063717A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104193798A (zh) * 2009-12-18 2014-12-10 Csl有限公司 纯化多肽的方法
EP2526115B1 (en) 2010-01-18 2018-08-01 Novo Nordisk Health Care AG Purification of blood coagulation factors
KR102058254B1 (ko) * 2011-03-29 2019-12-20 글락소스미스클라인 엘엘씨 단백질 정제용 완충제 시스템
CN103703015B (zh) * 2011-08-25 2019-07-05 霍夫曼-拉罗奇有限公司 阳离子和阴离子交换层析法
CN107406840B (zh) 2015-02-25 2021-05-28 奥姆里克斯生物药品有限公司 用于纯化和定量凝血酶及其降解多肽的方法
WO2016207328A1 (en) * 2015-06-24 2016-12-29 Glycotope Gmbh PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES
HRP20202077T1 (hr) * 2016-07-15 2021-02-19 F. Hoffmann - La Roche Ag Postupak za pročišćavanje pegiliranog eritropoetina
KR20220079844A (ko) * 2019-10-14 2022-06-14 피어스 바이오테크놀로지, 인크 펩티드 정제 제제 및 방법
JP2023090132A (ja) * 2021-12-17 2023-06-29 Kmバイオロジクス株式会社 ビタミンK依存性タンパク質のγ-カルボキシグルタミン酸修飾度の分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
IT1262899B (it) 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
RU2364626C2 (ru) * 2003-03-18 2009-08-20 Ново Нордиск Хелт Кэр Аг Способ получения, способ очистки и способ стабилизации полипептидов фактора vii, ix и x
ES2395544T3 (es) * 2004-12-23 2013-02-13 Novo Nordisk Health Care Ag Reducción del contenido de contaminantes proteínicos en composiciones que comprenden una proteína dependiente de la vitamina K de interés
WO2008104372A1 (en) * 2007-02-28 2008-09-04 Baxter International Inc. Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules

Also Published As

Publication number Publication date
EP2373677B1 (en) 2016-03-23
EP2373677A1 (en) 2011-10-12
AU2009324204A1 (en) 2010-06-10
CN102239175A (zh) 2011-11-09
US20110287518A1 (en) 2011-11-24
MX2011005474A (es) 2011-06-16
RU2544860C2 (ru) 2015-03-20
ES2576109T3 (es) 2016-07-05
JP2012510500A (ja) 2012-05-10
JP5788803B2 (ja) 2015-10-07
KR101821143B1 (ko) 2018-01-23
CA2742246A1 (en) 2010-06-10
RU2011125656A (ru) 2013-01-10
WO2010063717A1 (en) 2010-06-10
KR20110099251A (ko) 2011-09-07
AU2009324204B2 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
NL301046I2 (nl) Siponimod
BRPI0919237A2 (pt) purificação de policarbonatos
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0907457A2 (pt) Absorventes
BRPI0906764A2 (pt) Processos
PT2406399T (pt) Proteínas mirac
EP2420634A4 (en) CONNECTOR
EP2344029A4 (en) Electrode system
BRPI0907376A2 (pt) Fotobiorretador
EP2305405A4 (en) COATED ELEMENT
DK2598514T3 (da) Proteinoprensning
BRPI0813830A2 (pt) Purificação de polipeptídeos peguilados
BRPI0923541A2 (pt) purificação de imunoglobulina
BRPI0907522A2 (pt) biarlamidas
EP2259958A4 (en) LINKAGE
BRPI1010661A2 (pt) peptídeo
BRPI0922716A2 (pt) purificação de polipeptídeo
DE112009000183A5 (de) Sicherheitsvorreiber
BR112012006603A2 (pt) braçadeira de fixação
BRPI0909634A2 (pt) 2-aminoquinolinas
BRPI0922728A2 (pt) combinação de herbicida-antídoto
EP2261152A4 (en) REEL
BRPI0909637A2 (pt) 2-aminoquinolinas
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
EP2221104A4 (en) CLEANING CATALYST

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: NOVO NORDISK HEALTH CARE AG (CH)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B10A Cessation: cessation confirmed